Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,682.68
(
-0.50%
)
US TECH 100
24,014.00
(
-0.49%
)
Dow Jones
46,605.92
(
-0.82%
)
Brent Oil
105.25
(
4.57%
)
Bitcoin
71,242.90
(
-3.65%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122793
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: ghmm post# 85457

Sunday, 01/10/2010 8:33:16 PM

Sunday, January 10, 2010 8:33:16 PM

Post# of 257253
Addendum to the VRTX addendum: Today’s PR makes absolutely no mention of VX-813 and VX-985, which are purportedly the follow-on PI’s to succeed Telaprevir. Such a noteworthy omission bolsters my contention in the second paragraph of #msg-42917596 that the VX-813 and VX-985 programs are effectively dead.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now